Dolby Laboratories, Inc.
DLB
$75.34
$0.360.48%
NYSE
03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
---|---|---|---|---|---|
Net Income | 91.79M | 67.82M | 58.57M | 38.44M | 97.83M |
Total Depreciation and Amortization | 24.43M | 25.20M | 24.38M | 21.21M | 20.78M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 25.12M | 26.68M | 21.52M | 13.88M | 26.95M |
Change in Net Operating Assets | 33.56M | -12.92M | 11.70M | -52.27M | 35.86M |
Cash from Operations | 174.90M | 106.78M | 116.17M | 21.26M | 181.41M |
Capital Expenditure | -6.90M | -6.78M | -7.38M | -7.61M | -8.92M |
Sale of Property, Plant, and Equipment | 16.88M | -- | -- | -- | -- |
Cash Acquisitions | 0.00 | -1.36M | -487.88M | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 15.91M | -- | 233.95M | -131.00K | -8.96M |
Cash from Investing | 25.90M | -8.14M | -261.31M | -7.74M | -17.87M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 3.97M | 22.16M | 716.00K | 10.14M | 11.04M |
Repurchase of Common Stock | -36.77M | -47.44M | -21.65M | -36.37M | -26.49M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -31.83M | -31.55M | -28.61M | -28.70M | -28.72M |
Other Financing Activities | -241.00K | -740.00K | -10.58M | -3.46M | 0.00 |
Cash from Financing | -64.87M | -57.57M | -60.12M | -58.40M | -44.16M |
Foreign Exchange rate Adjustments | 2.77M | -7.16M | 4.38M | -857.00K | -3.68M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 138.69M | 33.91M | -200.87M | -45.73M | 115.70M |